Valeant's stock has plunged, so where are all the shorts? - The Globe and Mail
US-Pharmakonzern Valeant: Dieser Skandal könnte Bill Ackman Milliarden und den Ruf kosten - manager magazin
Valeant Pharmaceuticals Cuts Earnings and Sales Forecasts - The New York Times
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times
The rise and fall of Valeant Pharmaceuticals | CBC News
Valeant shares plunge after 'fraud' accusation from short-seller | CBC News
Netflix Dirty Money — An Interview With Erin Lee Carr
Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg
VALEANT SHORT SELLER: My new report won't have 'anything earth-shattering' - Business Insider India
Short Seller Famous for Bet Against Valeant Targets Tesla
Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete | LGT
Valeant 'short' smells smoke — even when there's no fire
Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham Transactions
The Valeant saga: Why the world needs short sellers
Drug Short - Watch Free Online
Valeant: Preispoker mit Medikamenten
Safkhet Capital's Quadir Is Still Short Valeant - YouTube
Citron Short Valeant Again
Die Shortsellerin, die schon 2018 gegen Wirecard wettete - Capital.de
Valeant: Just Short It (NYSE:BHC) | Seeking Alpha
Valeant Short Seller Dials Back Warning of Bombshell Report on Monday - WSJ
Andrew Left, owner and founder of Citron Research, stands for a... Nachrichtenfoto - Getty Images
Opinion: Time to short Valeant bonds, go long its stock - MarketWatch
Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete | LGT
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
